Ariana Nagel serves as Director, Product Development for UPM's R&D department.  She has spent 13 years in the pharmaceutical oral dosage industry designing products and developing processes within a CDMO atmosphere.  She has been involved with several products from concept through to commercial approval, including multiple peptide products.  She has extensive experience in a wide range of CMC practices for oral solid dosage form development.